跳至主要内容
临床试验/NCT06935214
NCT06935214尚未招募不适用

The Repeatability of the Effect of Caffeine Supplementation on Submaximal Physiological Responses and Cycling Time Trial Performance

St. Mary's University, Twickenham0 个研究点目标入组 12 人开始时间: 2025年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
12
主要终点
Blood lactate concentration

研究概览

简要总结

Recently, Grgic (2018) discussed the concept of responders and non-responders to caffeine supplementation highlighting the importance of the repeatability of results. However, the number of studies that have investigated this idea by repeating the same time-trial performance test multiple times with the same caffeine dose is sparse (Astorino et al., 2012; Del Coso et al., 2019). Furthermore, studies have shown that differences in the CYP1A2 genotype may account for some of the variation in time-trial performance (Guest et al., 2018). Thus, the current study aims to identify whether the effects of moderate caffeine supplementation (5 mg/kg) on time-trial performance are repeatable to aid the identification of responders and non-responders. Additionally, the study aims to determine if the CYP1A2 genotype may explain any of the variability in time-trial performance in trained male cyclists.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •To be considered for inclusion in the study, participants must be regular cyclists, between 18 and 35 years of age, capable of completing a 20 km cycling time trial at a minimum speed of 30 km/h (arbitrary inclusion criteria to ensure a sufficient standard of athlete).

排除标准

  • 未提供

研究组 & 干预措施

Caffeine

Experimental

5 mg/kg dose of caffeine (in pill form) - Trial 1

干预措施: Caffeine (Dietary Supplement)

Placebo

Placebo Comparator

5 mg/kg dose of placebo (Maltodextrin in pill form) - Trial 2

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Blood lactate concentration

时间窗: From baseline to completion, up to 31 days

Description: Change from baseline in blood lactate concentration measured at rest and at six different exercise intensities (55, 60, 65, 70, 75, and 80% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometer

Heart rate

时间窗: From baseline to completion, up to 31 days

Change from baseline in heart rate measured at rest and at seven different exercise intensities (55, 60, 65, 70, 75, and 80% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometer.

Oxygen uptake

时间窗: From baseline to completion, up to 31 days

Change from baseline in oxygen uptake measured at rest and at seven different exercise intensities (55, 60, 65, 70, 75, and 80% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometer

Perceived exertion

时间窗: From baseline to completion, up to 31 days

Change from baseline in rating of perceived exertion measured (using the 6-20 Borg scale) at seven different exercise intensities (55, 60, 65, 70, 75, and 80% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometer

Time trial completion time

时间窗: From baseline to completion, up to 31 days

Change from baseline in time to complete a time trial at a target amount of work on an electromagnetically-braked cycle ergometer calculated from the power output at maximal oxygen uptake and designed to last approximately 25 minutes.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验